Virax Biolabs Group Limited Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Inventories

Inventories

12 Months Ended

Mar. 31, 2022

Classes of current inventories [abstract]

Note 8 — Inventories


		As of March 31,
		2022				2021
Finished goods			30,951				31,072
Inventory write down			(10,000	)			(10,000	)
Inventory, net			20,951				21,072